Increased nasopharyngeal carriage of serotypes 6A, 6C, and 6D Streptococcus pneumoniae after introduction of childhood pneumococcal vaccination in Hong Kong

Diagnostic Microbiology and Infectious Disease

Volumn 76, Issue 2, 2013, Pages 153-157

  Ip, Margaret ^a   Chau, Shirley S L ^a   Lai, Lui S ^a   Ma, Helen ^a   Chan, Paul K S ^a   Nelson, E Anthony S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

6A; 6B; 6C; Serotype 6; Streptococcus pneumoniae; Surveillance

Indexed keywords

CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; LINCOMYCIN; LINEZOLID; MOXIFLOXACIN; PENICILLIN G; PNEUMOCOCCUS CONJUGATE VACCINE 7; PNEUMOCOCCUS VACCINE; TETRACYCLINE; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CHILD; CHILD HEALTH CARE; CONTROLLED STUDY; HONG KONG; HUMAN; INFANT; MAJOR CLINICAL STUDY; MICROBIOLOGICAL PHENOMENA AND FUNCTIONS; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NASOPHARYNGEAL CARRIAGE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; CEFOTAXIME; CHILD; CHILD, PRESCHOOL; FEMALE; HONG KONG; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NASOPHARYNX; PENICILLINS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, CONJUGATE;

EID: 84877808560     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.02.036     Document Type: Article

References (29)

1. Centers for Disease Control and Prevention (CDC) Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease: United States, 1998 -2003. MMWR Morb Mortal Wkly Rep 2005, 54:893-897.
2. Centers for Disease Control and Prevention (CDC) Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and Recommendations for use among children - Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010, 59:258-261.
3. Centre for Health Protection Scientific Committee on Vaccine Preventable Diseases. Recommendations on the use of pneumococcal vaccines, Hong Kong 2007.
4. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing, Twentieth informational supplement, 20th ed. M100-S20 2010, CLSI, Wayne, PA.
5. Committee on Infectious Diseases Recommendations for the Prevention of Streptococcus pneumoniae Infections in Infants and Children: Use of 13-valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23). Pediatrics 2010, 126:186-190.
6. Dagan R., Klugman K.P. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet 2008, 8:785-795.
7. Green M.C., Mason E.O., Kaplan S.L., Lamberth L.B., Stovall S.H., Givner L.B., et al. Increase in Prevalence of Streptococcus pneumoniae Serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009. J Clin Microbiol 2011, 49:2097-2101.
8. Greenberg D., Givon-Lavi N., Newman N., Bar-Ziv J., Dagan R. Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric pneumonia as a means to estimate serotype disease potential. Pediatr Infect Dis J 2011, 30:1-7.
9. Grijalva C.G., Nuorti J.P., Arthogast P.G., Martin S.W., Edwards K.M., Griffin M.R. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007, 369:1179-1186.
10. Huang S.S., Hinrichsen V.L., Stevenson A.E., Rifas-Shiman S.L., Kleinman K., Pelton S.I., et al. Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young Children. Pediatrics 2009, 124:e1-e11.
11. Ho P.L., Chiu S.S., Chan M.Y., Ang I., Chow K.H., Lau Y.L. Changes in nasopharyngeal carriage and serotype distribution of antibiotic-resistant Streptococcus pnuemoniae before and after the introduction of 7-valent pneumococcal conjugate vaccine in Hong Kong. Diagn Microbiol Infect Dis 2011, 71:327-334.
12. Ho P.L., Chiu S.S., Ang I., Lau Y.L. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009. Vaccine 2011, 29:3270-3275.
13. Ip M., Nelson E.A.S., Cheuk E.S.C., Sung R.Y.T., Li A., Ma H., et al. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from children hospitalized for acute respiratory illness in Hong Kong. J Clin Microbiol 2007, 45:1969-1971.
14. Jauneikaite E., Jefferies J.M., Hibberd M.L., Clarke S.C. Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review. Vaccine 2012, 30:3503-3514.
15. Jin P., Kong F., Xiao M., Oftadeh S., Zhou F., Liu C., et al. First report of putative Streptococcus pneumoniae serotype 6D among asopharyngeal isolates from Fijian children. J Infect Dis 2009, 200:1375-1380.
16. Jin P., Xiao M., Kong F., Oftadeh S., Zhou F., Liu C., et al. Simple, accurate, serotypes 6A, 6B, and 6C. J Clin Microbiol 2009, 47:2470-2474.
17. Ko K.S., Baek J.Y., Song J.H. Multidrug-resistant Streptococcus pneumoniae serotype 6D clones in South Korea. J Clin Microbiol 2012, 50:818-822.
18. Kuo C.Y., Hwang K.P., Hsieh Y.C., Cheng C.H., Huang F.L., Shen Y.H., et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine. Vaccine 2009, 29:5171-5177.
19. Moore M.R., Gertz R.E., Woodbury R.L., Barkocy-Gallagher G.A., Schaffner W., Lexau C., et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 2008, 197:1016-1027.
20. Nahm M.H., Lin J., Finkelstein J.A., Pelton S.I. Increase in the Prevalence of the Newly Discovered Pneumococcal Serotype 6C in the Nasopharynx after Introduction of Pneumococcal Conjugate Vaccine. J Infect Dis 2009, 199:320-325.
21. O'Halloran D.M., Cafferkey M.T. Multiplex PCR for Identification of Seven Streptococcus pneumoniae Serotypes Targeted by a 7-Valent Conjugate Vaccine. J Clin Microbiol 2005, 43:3487-3490.
22. Pai R., Gertz R.E., Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 2006, 44:124-131.
23. Park I.H., Pritchard D.G., Cartee R., Brandao A., Cristina M., Brandileone C., et al. Discovery of a New Capsular Serotype (6C) within Serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol 2007, 45:1225-1233.
24. Park I.H., Moore M.R., Treanor J.J., Pelton S.I., Pilishvili T., Beall B., et al. Differential Effects of Pneumococcal Vaccines against Serotypes 6A and 6C. J Infect Dis 2008, 198:1818-1822.
25. Rubin J.L., McGarry L.J., Strutton D.R., Klugman K.P., Pelton S.I., Gilmore K.E., et al. Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States. Vaccine 2010, 28:7634-7643.
26. Pilishvili T., Lexau C., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010, 201:32-41.
27. Song J.H., Dagan R., Klugman K.P., Fritzell B. The relationship between pneumococcal serotypes and antibiotic resistance. Vaccine 2012, 30:2728-2737.
28. Tocheva A.S., Jefferies J.M., Chiristodoulides M., Faust S.N., Clarke S.C. Increase in serotype 6C pneumococcal carriage, United Kingdom. EID 2010, 16:154-155.
29. Zhou F., Shefer A., Kong Y., Nuorti J.P. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics 2008, 121:253-260.